T. Rowe Price Investment Management »

Rapport Therapeutics shares owned by T. Rowe Price Investment Management

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by T. Rowe Price Investment Management from 13F filings

Historical chart of T. Rowe Price Investment Management investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by T. Rowe Price Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $35M 1.7M 20.48
2024-06-30 $36M 1.5M 23.26

More positions owned by T. Rowe Price Investment Management

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Fortive Corp Comm Stk (FTV)
Amazon Comm Stk (AMZN)
PTC Comm Stk (PTC)
Unitedhealth Group Comm Stk (UNH)
Revvity Comm Stk (RVTY)
Danaher Corporation Comm Stk (DHR)
Becton Dickinson & Co Comm Stk (BDX)
Roper Technologies Comm Stk (ROP)
Marvell Technology Comm Stk (MRVL)
Martin Marietta Matls Comm Stk (MLM)
Alphabet Comm Stk (GOOGL)
Apple Comm Stk (AAPL)
Hologic Comm Stk (HOLX)

View all positions for T. Rowe Price Investment Management

Top funds holding Rapport Therapeutics

Arch Venture Corp
Cormorant Asset Management
Capital Research and Management Company - Division 3
Johnson & Johnson
Sofinnova Ventures
T. Rowe Price Investment Management
Alliancebernstein
T. Rowe Price Associates
Perceptive Advisors
BlackRock
Citadel Advisors
Siren
Logos Global Management
Geode Capital Management
Woodline Partners

View all funds holding Rapport Therapeutics